Showing 1-10 of 5126 results for "".

• Combination Biologic and GLP-1 Receptor Agonist Therapy in Psoriasis

  https://practicaldermatology.com/topics/psoriasis/combination-biologic-and-glp-1-receptor-agonist-therapy-in-psoriasis/60858/
  New evidence indicates benefits of a dual-treatment strategy for many patients.
  • Text

•  Leadership Without Authority:Influencers of Culture in Your Practice 

  https://practicaldermatology.com/issues/may-june-2025/leadership-without-authority-influencers-of-culture-in-your-practice/35924/
  Influencers in popular culture demonstrate how individuals without formal authority can shape trends, ideas, and behavior. 
  • Text

• The Importance of Mentorship 

  https://practicaldermatology.com/youngmd-connect/wrap-ups/the-importance-of-mentorship/26950/
  The Importance of Mentorship 
  • Text

• Verrucous Psoriasis

  https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/
  Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,
  • Text

• The Role of HCC Coding in Dermatology

  https://practicaldermatology.com/topics/practice-management/the-role-of-hcc-coding-in-dermatology/56303/
  Hierarchical Condition Category (HCC) coding has become a cornerstone for risk adjustment in modern healthcare systems, serving to ensure appropriate reimbursement for providers managing patients with complex medical needs. 
  • Text

• June Issue: Melanoma Updates - Epidemiology, Diagnostics, and Treatment

  https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/
  In this article, we review the latest changes in melanoma incidence and mortality, highlight key disparities among minority populations, and summarize emerging trends in technology and treatment that are reshaping the future of melanoma care.
  • Text

• Analyzing Safety Data From Level Up

  https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/analyzing-safety-data-from-level-up/33944/
  The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versu
  • Audio

• The First 5 Minutes with a Patient

  https://practicaldermatology.com/videos/pa-perspectives/first-5-minutes-patient/27105/
  In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient. 
  • Video

• Promising Therapies on the Atopic Dermatitis Horizon

  https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37178/
  Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important potential developments in the atopic dermatitis pipeline
  • Video
  • Audio
  • Podcast
  • Transcript

• A Closer Look at OX40 Pathway Modulation

  https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/a-closer-look-at-ox40-pathway-modulation/50890/
  Walter Liszewski, MD, talks with Matthew Zirwas, MD, about the potential therapeutic applications, based on the article “Targeting the OX40-OX40L pathway: A new era in atopic dermatitis management by T-cell rebalancing,”1 as well as the risks of therapies targeting the OX40 pathway.
  • Video
  • Audio
  • Podcast
  • Transcript

• Prev
• 1
• 2
• 3
• …
• 512
• 513
• Next